Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Good Shroom Co Inc

Healthcare CA MUSH

0.14CAD
0.00(0%)

Last update at 2026-06-03T18:06:00Z

Day Range

0.140.14
LowHigh

52 Week Range

0.050.17
LowHigh

Fundamentals

  • Previous Close 0.14
  • Market Cap7.23M
  • Volume8900
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.17543M
  • Revenue TTM4.18M
  • Revenue Per Share TTM0.08
  • Gross Profit TTM 0.72M
  • Diluted EPS TTM-

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Type yearly yearly yearly yearly yearly
Date 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Income before tax -0.41231M 0.04M -0.45214M -1.62896M -3.84947M
Minority interest - - - - -
Net income -0.41231M 0.04M -0.45214M -1.62896M -3.84947M
Selling general administrative 0.98M 1.15M 1.09M 1.76M 3.45M
Selling and marketing expenses - - - - -
Gross profit 0.62M 1.23M 0.67M 0.23M 0.06M
Reconciled depreciation 0.02M 0.02M 0.02M 0.06M 0.06M
Ebit - - - -1.57137M -2.16787M
Ebitda - - - -1.56397M -3.78984M
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income -0.41016M 0.05M -0.44773M -1.60708M -3.47559M
Other operating expenses - - - 0.01M 0.03M
Interest expense 0.00095M 0.00435M 0.00130M 0.00443M 0.00210M
Tax provision - - - - -
Interest income - - - - -
Net interest income -0.00095M -0.00435M -0.00370M -0.01909M -0.14777M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue 3.00M 3.89M 3.16M 1.22M 0.24M
Total operating expenses 3.41M 3.85M 3.61M 2.82M 3.72M
Cost of revenue 2.37M 2.67M 2.50M 0.99M 0.18M
Total other income expense net -0.00121M -0.00313M -0.00070M -0.00279M -0.22611M
Discontinued operations - - - - -
Net income from continuing ops -0.41231M 0.04M -0.45214M -1.62896M -3.84947M
Net income applicable to common shares - - - -1.62896M -3.84947M
Preferred stock and other adjustments - - - - -
Breakdown 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Type yearly yearly yearly yearly yearly
Date 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Total assets 1.02M 1.48M 1.44M 1.64M 2.30M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets - - - - -
Total liab 0.78M 0.90M 0.99M 0.88M 0.50M
Total stockholder equity 0.24M 0.58M 0.46M 0.76M 1.80M
Deferred long term liab - - - - -
Other current liab - - - - 0.05M
Common stock - - - 10.65M 10.55M
Capital stock 11.32M 11.11M 11.08M 10.65M 10.55M
Retained earnings -13.16757M -12.75526M -12.79586M -12.34372M -10.71476M
Other liab - - - 0.02M 0.02M
Good will - - - - -
Other assets - - - - -
Cash 0.39M 0.20M 0.38M 0.68M 1.62M
Cash and equivalents - - - - -
Total current liabilities 0.78M 0.90M 0.97M 0.71M 0.27M
Current deferred revenue - - - - -
Net debt - - - - -
Short term debt - - - - -
Short long term debt - - 0.04M - -
Short long term debt total - - - - -
Other stockholder equity - - - - -
Property plant equipment - - - 0.20M 0.26M
Total current assets 1.00M 1.45M 1.39M 1.45M 2.04M
Long term investments - - - - -
Net tangible assets - - - 0.76M 1.80M
Short term investments - - - 0.07M 0.07M
Net receivables 0.18M 0.68M 0.53M 0.24M 0.09M
Long term debt - - - 0.04M 0.04M
Inventory 0.43M 0.53M 0.45M 0.39M 0.19M
Accounts payable 0.78M 0.88M 0.89M 0.45M 0.08M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total 0.02M 0.04M 0.06M 0.20M 0.26M
Capital lease obligations 0.00000M 0.02M 0.03M 0.17M 0.22M
Long term debt total - - - - -
Breakdown 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Type yearly yearly yearly yearly yearly
Date 2025-07-31 2024-07-31 2023-07-31 2022-07-31 2021-07-31
Investments - 0.00000M 0.07M 0.00000M -0.07000M
Change to liabilities - - - 0.54M 0.06M
Total cashflows from investing activities - - - - 2.58M
Net borrowings -0.01800M -0.05800M - -0.16000M 0.24M
Total cash from financing activities -0.01800M -0.02802M -0.01800M -0.16000M 0.25M
Change to operating activities - - - 0.00472M -0.01168M
Net income -0.41231M 0.04M -0.45214M -1.62896M -3.84947M
Change in cash 0.19M -0.17605M -0.30313M -0.93778M 1.11M
Begin period cash flow 0.20M 0.38M 0.68M 1.62M 0.50M
End period cash flow 0.39M 0.20M 0.38M 0.68M 1.62M
Total cash from operating activities 0.21M -0.14804M -0.35513M -0.77778M -1.71426M
Issuance of capital stock - - - - -
Depreciation 0.02M 0.02M 0.02M 0.06M 0.06M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory 0.10M -0.08027M -0.06030M -0.19923M -0.10545M
Change to account receivables - -0.15589M -0.28897M -0.14857M -0.06275M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - - - -0.01333M
Change to netincome - - - 0.60M 2.17M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.02M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.53M -0.24633M -0.07354M 0.19M -0.09172M
Stock based compensation 0.07M 0.05M 0.15M 0.59M 0.58M
Other non cash items 0.00047M 0.00147M 0.00240M 0.00931M 1.59M
Free cash flow 0.21M -0.14804M -0.35513M -0.77778M -1.73493M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
MUSH
Good Shroom Co Inc		 - -% 0.14 - - 1.73 21.02 1.57 3079.29
RX
Biosyent Inc.		 0.12 0.87% 13.95 19.10 15.85 3.96 4.11 3.31 11.03
DB
Decibel Cannabis Company Inc		 -0.005 4.17% 0.12 - 8.67 0.67 1.20 0.99 17.75
ZYUS
ZYUS Life Sciences Corporation		 - -% 0.50 - - 108.48 4.41 140.29 -4.258
LSL
LSL Pharma Group Inc.		 - -% 0.33 20.75 - 1.88 1.89 2.85 10.19

Reports Covered

Stock Research & News

View All

Profile

Mercanto Holdings Inc. operates in cannabis and wellness industries in Canada and the United States. It engages in the production and sale of cannabis-based products and beverages. The company was formerly known as The Good Shroom Co Inc. and changed its name to Mercanto Holdings Inc. in February 2025. Mercanto Holdings Inc. is headquartered in Québec, Canada.

Good Shroom Co Inc

11 Beacon Street, Québec, QC, Canada, H9J 2E9

Key Executives

Name Title Year Born
Mr. Eric Ronsse Pres, CEO & Chairman 1989
Mr. Scott Jardin Chief Financial Officer 1978
Ms. Anik Gendron Corp. Sec. 1971
Mr. Eric Ronsse President, CEO & Chairman 1989
Mr. Scott Jardin CPA, CGA Chief Financial Officer 1979
Mr. Peter Ho Operations Manager NA
Ms. Anik Gendron Corporate Secretary 1971
Mr. Eric Ronsse President, CEO & Chairman 1988
Mr. Scott Jardin CPA, CGA Chief Financial Officer 1978
Ms. Anik Gendron Corporate Secretary 1972

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.